R&D News | pharmaphorum

News

Sionna has closed its IPO, raising $191m for cystic fibrosis candidates that it thinks could be more effective than rivals from Vertex.

News

Billions of dollars will be cut from medical research funding provided by the NIH in the latest money-saving programme from the Trump administration.

News

MSD has started a phase 3 trial of ROR1-directed ADC zilo-V as a treatment for previously untreated diffuse large B-cell lymphoma.

News

After its first phase 3 trial of obesity hope CagriSema left investors dissatisfied, Novo Nordisk has a plan to get the programme back on track.

News

Robert F Kennedy Jr has cleared a key obstacle in his bid to become the next HHS Secretary after the Senate Finance Committee voted in his favour.

News

A GABA-targeting drug developed by German Biotech Algiax has shown proof of concept in a chronic neuropathic trial trial.